This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Checking in with a prescriber of Sohonos (palovarotene) as a treatment for heterotopic ossification.
Ticker(s): IPSEYWho's the expert?
Institution: Penn Medicine
- Orthopaedic trauma and fracture surgeon, treating broken bones and injuries of the arms, legs and pelvis.
- Performs over 100 bone grafting procedures annually.
- Comfortable discussing the FDA approval of OsteoFlo HydroPutty and how it might compare with current bone graft technology.
Interview Goalto discuss the current treatment landscape and the use of Sohonos (palovarotene) as a treatment for heterotopic ossification.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
